Genetic Diversity and Selective Pressure in Hepatitis C Virus Genotypes 1–6: Significance for Direct-Acting Antiviral Treatment and Drug Resistance

Viruses - Switzerland
doi 10.3390/v7092857
Full Text
Abstract

Available in full text

Date
Authors
Publisher

MDPI AG

Related search

Hepatitis C Virus Cell-Cell Transmission and Resistance to Direct-Acting Antiviral Agents

PLoS Pathogens
ImmunologyMolecular BiologyVirologyMicrobiologyParasitologyGenetics
2014English

Direct-Acting Antiviral Drugs and Hepatitis C Virus: A Therapeutic Revolution?

Cancer
Cancer ResearchOncology
2015English

Oral Direct-Acting Antiviral Therapy for Hepatitis C

Journal of Antivirals & Antiretrovirals
2012English

Pharmacokinetic Considerations for Combining Antiretroviral Therapy, Direct-Acting Antiviral Agents for Hepatitis C Virus, and Addiction Treatment Medications

Clinical Pharmacology in Drug Development
PharmacologyPharmaceutical Science
2017English

Systematic Review: Cost-Effectiveness of Direct-Acting Antivirals for Treatment of Hepatitis C Genotypes 2-6

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Direct-Acting Antiviral Treatment for Hepatitis C Virus Infection and Risk of Incident Liver Cancer: A Retrospective Cohort Study

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

A Cost-Effectiveness Analysis of Shortened Direct-Acting Antiviral Treatment in Genotype 1 Noncirrhotic Treatment-Naive Patients With Chronic Hepatitis C Virus

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2019English

Persistent Hepatitis C Virus-Associated Cryoglobulinemic Vasculitis Following Virus Eradication After Direct-Acting Antiviral Therapy

Hepatology
MedicineHepatology
2017English

Development of Proteinuria and Focal Segmental Glomerulosclerosis During Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection

Hepatology
MedicineHepatology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy